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ABSTRACT (200 words) 25 
Upper limb myoelectric prostheses remain challenging to use and are often abandoned. A proficient 26 
user must be able to plan/execute arm movements while activating the residual muscle(s), accounting 27 
for delays and unpredictability in prosthesis response. There is no validated, low cost measure of skill in 28 
performing such actions. Trial-trial variability of joint angle trajectories measured during functional task 29 
performance, linearly normalised by time, shows promise. However, linear normalisation of time 30 
introduces errors, and expensive camera systems are required for joint angle measurements.  31 
This study investigated whether trial-trial variability, assessed using dynamic time warping (DTW) 32 
of limb segment acceleration measured during functional task performance, is a valid measure of user 33 
skill. Temporal and amplitude variability of forearm accelerations were determined in 1) seven 34 
myoelectric prosthesis users and six anatomically-intact controls and 2) seven anatomically-intact 35 
subjects learning to use a prosthesis simulator over repeated sessions.  36 
1: temporal variability showed clear group differences (p<0.05). 2: temporal variability 37 
considerably increased on first use of a prosthesis simulator, then declined with training (both p<0.05). 38 
Amplitude variability showed less obvious differences. Analysing forearm accelerations using DTW 39 
appears to be a valid low-cost method for quantifying movement quality of upper limb prosthesis use 40 
during goal-oriented task performance. 41 
 42 
Keywords 43 
Myoelectric prostheses, dynamic time warping, accelerations, variability, upper limb. 44 
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1. INTRODUCTION 46 
As a result of concerted efforts over recent decades, there have been significant advances in myoelectric 47 
prostheses design. The motors used have become smaller and more powerful, cosmetic covers have 48 
become more life-like, and, of most note, multi-functional hands, such as the i-Limb (Touch Bionics, 49 
Livingston, UK) and Be-Bionic (Steeper, Leeds, UK) have been developed. Yet, prosthesis users are still 50 
greatly limited by the available control modalities and lack of sensory feedback from the prosthesis [1]. 51 
Hence it is not surprising that such devices remain challenging to use and are often poorly utilized, or 52 
rejected [2, 3]. As more expensive multi-function myoelectric prostheses have become available, such as 53 
the i-limb full hand and i-limb digits (Touchbionics Inc., Livingston UK),  there is an urgent need for well-54 
validated and robust quantitative measures that allow for informed selection of a particular technology 55 
(to achieve a better match between user and device), and that have the potential to inform user 56 
training.  57 
 58 
Currently, quantifying the effectiveness of a given device, or the proficiency with which it is used, 59 
remains limited by the available outcome measures [4].Clinical tests often capture self-reported 60 
capabilities (e.g.  Orthotics and Prosthetics Users' Survey “OPUS” [5]), evaluate performance subjectively 61 
(e.g. Assessment of capacity for myoelectric control [6]), or measure speed of performance of a pre-62 
defined set of tasks (e.g. Southampton Hand Assessment Procedure “SHAP”  [7]). Research has 63 
discussed the limitations with many of these measures, such as reliance upon self-report and/or 64 
observer ratings [8-10]; self-report does not directly measure the person’s physical capabilities and can 65 
be influenced by subject bias, and observer-dependent measures are susceptible to (inter-/intra-) rater 66 
bias, which inherently reduces reliability compared to performance-based measures in which the 67 
administrator does not form part of the instrument. Previous research has also shown that whilst 68 
important [10], speed of task completion is only one of several factors which characterize skilled 69 
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prosthetic use; other measures, notably gaze and kinematics may further enhance our understanding of 70 
user performance and skill level [11].  71 
 72 
Accordingly, Major et al. recently compared the kinematics of myoelectric prosthesis users and able-73 
bodied controls without known pathology [12]. Specifically, considering that motor variability (motor 74 
variance across task repetition) has shown to decrease with skill acquisition [13, 14], and given the 75 
redundant degrees of freedom (DoFs) in the upper body musculoskeletal architecture that permit 76 
various task-equivalent motor strategies, Major et al. [12] focused on studying kinematic variability of 77 
these DoFs. Their results showed that joint kinematic variability is higher in prosthesis users than 78 
controls, and was correlated with years of experience of prosthesis use.  Their findings suggest that 79 
increased compensation may be reflected in increased joint kinematic variability above able-bodied 80 
individuals. 81 
 82 
In common with almost all studies of upper limb functional task performance, in [12] joint angle 83 
trajectories were calculated as follows. Angle trajectories were first linearly normalized with respect to 84 
time, and joint level kinematic variability was defined as the variability around a kinematic profile 85 
averaged across multiple time-normalized trials. The standard deviation and coefficient of multiple 86 
determination then served as outcome measures to characterize variability and repeatability, 87 
respectively. However, non-cyclic kinematics are subject to two different aspects of trajectory 88 
variability: temporal and amplitude variability (Figure 1). Specifically, the relative duration of different 89 
phases of a given functional movement can vary from trial to trial, and linear time normalization of the 90 
entire task cannot take this into account [15]. Hence, while these traditional measures can inform on 91 
overall differences in movement variability, they remain limited in that they do not consider temporal 92 
variability separately to variations in signal amplitude, yet this has shown to be advantageous in the 93 
assessment of non-cyclic functional upper limb tasks [15,16]. 94 
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Thies et al. previously introduced a novel methodology based on dynamic time warping (DTW) for curve 95 
registration across multiple trials to calculate measures of amplitude and timing variability over entire 96 
trajectories of functional movements [15]. In their approach a chosen target signal is warped to a 97 
declared reference signal by compressing or stretching the target signal along the time-axis with respect 98 
to the reference signal in a non-uniform manner. Warp Cost reflects the amount of time-warping 99 
needed to achieve the best possible temporal match between curves and serves as a measure of 100 
temporal variability. Following the time warping of signals, RMS error then informs on amplitude 101 
variability.  Separating out temporal from amplitude variability is of particular advantage during 102 
processing of non-cyclic upper limb kinematics: we take the stand that DTW is a more appropriate 103 
method to analyse kinematic inter-trial variability of the upper limbs during functional task performance 104 
since it minimizes the mismatch of the different movement components (Figure 2). 105 
 106 
A first demonstration of the DTW method involved characterization of acceleration trajectories derived 107 
from an arm-worn accelerometer during performance of two daily-living activities in subjects with 108 
stroke and matched controls. Findings showed increased timing variability for the stroke subjects as 109 
compared to controls, and this outcome was reliably reproduced on a second test day one month later 110 
[15]. This finding of increased variability following stroke was consistent with numerous previous 111 
studies, which have generally used simpler tasks and discrete, rather than continuous, measures of 112 
variability (e.g. variability of end point error in pointing tasks [17, 18]. A more recent study used the 113 
DTW method to demonstrate differences in trajectory variability when comparing stroke survivors with 114 
right and left hemisphere lesions, as well as to healthy controls [16]. They showed increased timing 115 
variability in the paretic arm of stroke survivors with right compared with left hemisphere lesions and 116 
further confirmed previous finding [15] of increased variability following stroke compared with controls. 117 
The DTW method which assesses contributions of temporal and amplitude variability separately proved 118 
particularly suitable to identify differences between left and right hemispheric stroke survivors. 119 
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Although already demonstrated for assessment of upper limb kinematics in people with stroke, the 120 
potential and validity of this methodology to characterize upper limb movements in relation to 121 
functional performance for upper limb prosthesis users has yet to be explored.   Hence this paper 122 
reports on the characterization of functional task performance with an upper limb myoelectric 123 
prosthesis using the DTW method. The purpose of this retrospective study was to investigate whether 124 
DTW is a valid tool for assessing temporal and amplitude variability of upper limb prosthesis kinematics 125 
through a known-groups assessment (Study 1) and a responsiveness assessment (Study 2).  126 
 127 
2. METHODS 128 
In Study 1 we investigated the use of DTW to characterize upper limb function of myoelectric prosthesis 129 
users and anatomically intact (AI) controls and its ability to discriminate between these two groups, 130 
based on temporal and amplitude variability. In Study 2 we report on the changes in temporal and 131 
amplitude variability with practice in using a myoelectric prosthesis simulator (AI subjects), to assess if 132 
DTW can identify changes in temporal and amplitude variability resulting from practice of goal-oriented 133 
tasks. Since accelerometers are wearable, inexpensive and clinically-accessible devices, we here apply 134 
DTW to simulated accelerometer trajectories derived from position data, however, the method is 135 
applicable to a range of kinematic data, including joint angle trajectories and data from other segment-136 
mounted inertial measurement units. 137 
 138 
2.1 DTW for assessment of temporal and amplitude variability 139 
As previously described [15], the DTW method employed in these two studies utilized dynamic 140 
programming [19] to separately quantify timing and amplitude variability across multiple trials. Using 141 
custom software in Matlab (Mathworks, Natick, MA), the algorithm first time-warps a chosen target 142 
signal to a declared reference signal by compressing or stretching the target signal along the time-axis 143 
with respect to the reference signal in a non-uniform manner. Warp Cost is returned as a unitless 144 
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measure indicating the amount of time-warping needed to achieve the best possible temporal match 145 
between curves. Warp Cost is hence reported as a measure of temporal variability between trials. Figure 146 
3 stresses the need for DTW for accurate assessment of upper limb kinematic variability in an 147 
anatomically intact subject, an anatomically intact subject using a prosthesis simulator, and an actual 148 
prosthesis user. After time warping, the algorithm calculates the remaining root mean square error 149 
(RMS Error) between signals after time-warping is complete. We interpret the reported RMS Error as a 150 
measure of signal amplitude variations after temporal variations have been addressed.  151 
 152 
2.2 Study 1 (Known-groups assessment)  153 
Study 1 was carried out at Northwestern University, USA. Full details of the protocol are provided in [12]. 154 
Following ethical approval by the Northwestern University Institutional Review Board, six AI individuals (3 155 
male, 35±11 years of age) and seven myoelectric transradial prosthesis users (5 male, 49±18 years of age, 156 
20±18 years of prosthesis experience) were recruited and tested. Subjects visited the lab on one occasion 157 
and, after providing informed consent, performed five trials of three seated, goal-oriented tasks (selected 158 
from the SHAP [7]): 1) lifting a carton and emptying liquid contents into a jar using their non-dominant or 159 
prosthetic limb, 2) lifting and transferring a weighted container across a low-level barrier using their non-160 
dominant or prosthetic limb, and 3) lifting and transferring a tray across a low-level barrier using both 161 
hands. The non-dominant limb of able-bodied individuals was chosen for sensible comparison with 162 
prosthesis users whose prosthetic limb we assumed to act as the non-dominant limb [20]. The number of 163 
trials (5) was comparable with other studies concerned with assessment of prosthesis kinematics [21, 22]. 164 
Subjects were asked to perform the task as quickly as possible and the start and end of each trial was 165 
denoted by a button-push. Both groups also completed the entire SHAP protocol with their non-dominant 166 
hand to assess general upper limb functional abilities. SHAP has shown to have good reliability and validity 167 
for assessment of hand function [7], with scores of less than 100 indicating how impaired hand function 168 
is. During each task, marker position approximating location of the radial and ulnar styloid processes were 169 
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collected and used to track the virtual wrist joint centre. Three markers on the forearm (radial styloid, 170 
ulnar styloid, and medial epicondyle) were used to define the forearm local reference frame. The 3D 171 
position data were collected at 120 Hz using a twelve camera motion capture system (Motion Analysis 172 
Corporation, Santa Rosa, CA, USA).  Wrist joint three-axis accelerations were calculated in the global 173 
frame, then gravity was added to the vertical acceleration component. Finally, the acceleration vector 174 
was rotated from the global to the forearm frame [23]. These simulated accelerometer data were used to 175 
calculate inter-trial temporal (Warp Cost) and amplitude (RMS Error) variability [15]. 176 
 177 
This known-groups assessment was deemed to support validity of the methodology if the trends in the 178 
variability assessed with DTW reflected those previously observed in joint-level kinematics [12], i.e., we 179 
hypothesized that prosthesis users would demonstrate greater variability than controls. Moreover, use of 180 
DTW in this study would identify individual contributions of temporal- and amplitude-specific variability 181 
to overall movement variability. Data were statistically analysed using independent group t-tests to 182 
compare mean differences in Warp Cost, RMS Error, and SHAP score between AI and prosthesis user 183 
cohorts, and significance was evaluated based on equality of variances as estimated by the Levene’s Test. 184 
 185 
2.3 Study 2 (Responsiveness assessment) 186 
Study 2 was carried out at the University of Salford, UK. Following ethical approval by the University of 187 
Salford Research Ethics Committee, seven AI individuals (4 male, 6 right handed, 36±10 years of age) 188 
provided informed consent and were recruited to the study. AI subjects rather than novel myolecetric 189 
prosthesis users were recruited because of the very small numbers of traumatic upper limb amputees 190 
referred to limb fitting centres. For example, in 2004/5, there were just 54 new referrals of trans-radial 191 
amputees in the UK. Subjects visited the lab on 9 occasions over approximately a 2-week period; full 192 
details of the full protocol are published in [24], however, only a subset of visits is reported on here. On 193 
their first visit, subjects were asked to perform a seated task which involved reaching with their 194 
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anatomic hand for a juice carton, picking it up and pouring the liquid into a cup, before returning it to its 195 
original location, then moving their hand back to the original resting point (anatomic hand baseline). The 196 
location of the carton, cup and starting point for the hand were fixed for each subject across all trials. 197 
Subjects repeated the task 12 times. During their second functional task assessment as well as during 198 
their final functional task assessment, subjects performed the same task with the same number of 199 
repeats but with a custom-made myoelectric prosthesis simulator [24]. In between these prosthesis 200 
simulator sessions, subjects carried out the SHAP on four occasions for practicing with the prosthesis 201 
simulator. During task performance, 3D position data of a cluster of 4 reflective markers located on the 202 
forearm were collected at 100 Hz using a ten camera Vicon 612® motion capture system (Vicon Motion 203 
Systems, Los Angles, USA). The position data of their anatomic hand baseline, their first prosthesis 204 
simulator session, and their final session with the prosthesis simulator (after SHAP training) were then 205 
used to calculate the simulated output of a three-axis accelerometer [23]. Subsequently, temporal and 206 
trajectory variability within session were calculated. It was hypothesized that introduction of the 207 
prosthesis would increase variability (anatomic baseline versus initial Prosthesis simulator session), and 208 
that training through practice to use a prosthesis simulator would reduce variability. Following checks 209 
for their normal distribution, warp cost and remaining RMS error were statistically analyzed using a one-210 
way repeated measures ANOVA (SPSS General Linear Model tab) with post-hoc Bonferroni correction 211 
for Type 1 Error. 212 
 213 
For all statistical analyses, the critical α was set at 0.05 to guide interpretation of the results, and 214 
statistics were conducted using SPSS software (IBM, Armonk, New York).  215 
 216 
 217 
 218 
 219 
Page 10 of 24 
 
3. RESULTS 220 
 221 
3.1 Study 1 (Known-groups assessment) 222 
Significant differences in temporal variability (Warp Cost) were found between prosthesis-users and 223 
able-bodied controls. Specifically, prosthesis users exhibited greater temporal variability than controls, 224 
and this was so for all three tasks (Figure 4 and Table 1). Results suggested that amplitude variability 225 
was greater for prosthesis users than able-bodied across tasks, but these group differences were not 226 
statistically significant (P>0.05 for all tasks, Figure 4 and Table 1). Average SHAP Index of Function scores 227 
for able-bodied and prosthesis users were 96(±3 SD) and 53(±12 SD) (p<0.001), respectively, suggesting 228 
lower upper limb functional abilities for prosthesis users. 229 
 230 
3.2 Study 2 (Responsiveness assessment)  231 
Clear changes in temporal variability emerged throughout the study period (Figure 5 (left) and Table 2). 232 
Specifically, when AI subjects were asked to use the prosthesis simulator for the first time, their 233 
temporal variability increased as compared to their baseline performance with the anatomical hand 234 
(P=0.022), but as they learned how to use the prosthesis simulator, their variability decreased again 235 
(P=0.043) and returned to levels similar to baseline (P=0.267). Changes in amplitude variability likewise 236 
emerged, although with a direction of continuous reduction in RMS Error throughout the study period 237 
(Figure 5 (right) and Table 2). Specifically, RMS Error slightly decreased from baseline as subjects were 238 
introduced to the prosthesis simulator (P=1.000), and a further reduction in RMS Error occurred with 239 
practice to use the simulator (P=0.003), interestingly to levels much lower than baseline (P=0.043). 240 
 241 
 242 
 243 
 244 
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4. DISCUSSION 245 
The combined results from Studies 1 and 2 support the validity and usefulness of the DTW method for 246 
characterizing movement quality of task execution when using an upper limb prosthesis. Study 1 found 247 
significant differences in temporal inter-trial variability between prosthesis users and controls, but not in 248 
amplitude variability. This finding demonstrates for the first time the nature of differences in trial-to-249 
trial variability between experienced users of myoelectric prostheses and controls. Specifically, by 250 
separating out the two elements of trajectory variability, DTW revealed the primary contribution of 251 
temporal variability to overall movement quality, with less apparent contributions of amplitude 252 
variability. Moreover, that prosthesis users exhibited greater kinematic variability as compared to 253 
controls across all three tasks along with reduced function, as quantified by lower SHAP scores, is in 254 
agreement with previous findings [12], thereby supporting the validity of this method. It should be 255 
noted that one of the possible reasons for the lack of statistical significance in amplitude variability was 256 
the low statistical power due to a small sample size. Although consistent group differences in amplitude 257 
variability existed across tasks, with magnitudes greater than those found with training in Study 2, these 258 
differences were not large enough to reach significance given the within-group variability. 259 
 260 
Although not unexpected, no-one has previously demonstrated that variability reduces with practice 261 
with a prosthesis simulator. In Study 2 we investigated the extent by which temporal and amplitude 262 
variability each contribute to this outcome and demonstrated that temporal variability in a carton 263 
pouring task increased considerably on first use of a prosthesis simulator, then declined with goal-264 
oriented training (SHAP). Temporal variability hence showed to be responsive to effects of training. 265 
Consistent with the findings in Study 1, amplitude variability showed less clear changes, especially on 266 
first introduction of the prosthesis simulator. Two limitations of Study 2 are that AI subjects used a 267 
prosthesis simulator and performed only one functional task. Therefore further research involving actual 268 
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myoelectric prosthesis users and a more comprehensive task protocol is required to substantiate the 269 
findings of Study 2. 270 
 271 
Consistent with our previous study in stroke [15] temporal variability, as compared to amplitude 272 
variability, emerged as the more insightful measure.  As all of the tasks studied involved acquiring and 273 
releasing objects using the prosthetic hand, and since opening the hand to acquire or release an object 274 
is a common challenge in prosthesis control, then hesitations upon grasp and release may be one of the 275 
sources of the higher timing variability seen in prosthesis users. It is noteworthy that temporal variability 276 
varied significantly across tasks (see Table 1), each of which involved a single grasp and release, and 277 
further work is needed to interpret this finding. Furthermore, given the trends observed in Studies 1 and 278 
2, higher prosthesis user amplitude variability and a decrease with simulator training respectively, the 279 
contribution of amplitude variability to movement quality should be explored further. Previous work has 280 
suggested that below-elbow amputees are able to generate an accurate internal model of the prosthetic 281 
limb [25] which implies self-integration of the limb to refine relationships between physiological input 282 
and performance output. For example, one explanation for the decrease in amplitude variability with 283 
practice (Figure 5) is that learning to use a prosthesis simulator with reduced DoFs may require some 284 
development of a new internal model with training to minimize limb amplitude variability. The increase 285 
(Prosthesis 1, Figure 5) and subsequent decrease (Prosthesis Final, Figure 5) in temporal variability upon 286 
introduction to the prosthesis simulator would be reflective of skill acquisition.  287 
 288 
Overall, analysing forearm accelerations using the DTW method appears to be a valid method for 289 
quantifying movement quality of upper limb prosthesis use during the execution of goal-oriented tasks.  290 
The information delivered from such assessment offers a valuable, objective outcome for monitoring 291 
rehabilitation progress that would complement other performance-based and self-report clinical 292 
outcome measures. A rich set of outcome data would aid in development of more appropriate, patient-293 
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centric training programs with the aim of maximizing functional performance and minimizing potential 294 
for device abandonment. Yet, further work is needed to understand the implications of our work for 295 
clinical training.  We have shown that in simulator users both amplitude and temporal trajectory 296 
variability decrease with practice, suggesting our metrics may be of value in assessing skill. However, 297 
research is needed to understand whether patients would benefit from training specifically targeted at 298 
reducing variability.  299 
 300 
Importantly, the studies reported here used camera based techniques to derive overall task completion 301 
time and simulated accelerometer trajectories. However, both of these parameters could be derived 302 
from a forearm-mounted accelerometer and hence the approach offers the potential for clinicians to 303 
characterise both overall task completion time and trial-trial temporal and trajectory variability using 304 
low cost instrumentation. Accelerometers have previously been used for classification of hand 305 
movements [26, 27], and this study shows their potential in assessment of kinematic variability as an 306 
aspect of movement quality. Future work should continue to explore use of wearable devices as a 307 
simple, reliable, and clinically-accessible method for assessing prosthesis-use skill. When combined with 308 
the use of low cost instrumentation, reliability of the DTW method for assessing prosthesis user 309 
movement quality should be investigated to complete an evaluation of its psychometric properties. 310 
 311 
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TABLES 394 
Table 1. Known-groups assessment (Study 1)  395 
 Group 
Carton Pouring 
Weighted Container 
Transfer 
Tray Transfer 
Mean (SD) 
P  
[95% CI] 
Mean (SD) 
P  
[95% CI] 
Mean (SD) 
P  
[95% CI] 
Warp 
Cost 
Anatomically 
Intact 
85.80 (27.14) 0.02 
[-158.55, 
-18.33] 
6.92 (2.31) 
0.004 
[-
100.63,  
-29.03] 
13.55 (9.14) 0.019 
[-73.96,    
-9.40] 
Prosthesis 
User 
174.24 (74.48) 71.75 (38.71) 55.23 (34.70) 
RMS 
Error 
[m/s2] 
Anatomically 
Intact 
0.60 (0.09) 0.07 
[-934.53, 
43.69] 
0.93 (0.28) 
0.127 
[-
750.20, 
106.65] 
1.26 (0.41) 0.164 
[-833.74, 
160.12] 
Prosthesis 
User 
1.04 (0.53) 1.25 (0.40) 1.60 (0.41) 
 396 
Group mean (standard deviation “SD”) and statistical t-test results for Warp Cost and RMS Error for the 397 
three functional tasks. 95%CI: 95% Confidence Interval of Mean Difference. 398 
 399 
Table 2. Responsiveness assessment (Study 2)    400 
 
Warp Cost RMS Error [m/s2] 
Mean (SD) 
P†  
[95% CI] 
Mean (SD) 
P† 
[95% CI] 
Anatomic 60.45 (17.02) 
0.022 
[-141.55; -13.07] 
0.47 (0.09) 
1.000 
[-0.15; 0.19] Prosthesis 1 
137.77 
(43.92) 
0.45 (0.07) 
Prosthesis 1 
137.77 
(43.92) 0.043 
[2.15; 125.48] 
0.45 (0.07) 
0.003 
[0.05; 0.18] Prosthesis 
Final 
73.95 (19.27) 0.33 (0.04) 
Prosthesis 
Final 
73.95 (19.27) 0.267 
[-8.38; 35.37] 
0.33 (0.04) 0.043 
[-0.26; -0.01] 
Anatomic 60.45 (17.02) 0.47 (0.09) 
†Adjustment for multiple comparisons: Bonferroni. 401 
Group mean (standard deviation “SD”) of Warp Cost and RMS Error for AI subjects at baseline (anatomic 402 
hand) and during learning to use a prosthesis simulator (myoelectric prosthesis) together with repeated 403 
measures GLM pairwise comparisons for test sessions. 95%CI: 95% Confidence Interval of Mean 404 
Difference. 405 
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FIGURE CAPTIONS  406 
Figure 1. Illustration of temporal and amplitude variability.  407 
Figure 2. Illustration of the effects of uniform time normalization as compared to DTW. Example 408 
(adapted from Thies et al. 2009): “drinking from a glass” involves a reach forward, grasp of the glass, 409 
lifting, drinking and replacing the glass onto the table top. Note that for uniform time normalization 410 
(left) trials remain inadequately aligned, as evident from the mismatch of the different movement 411 
components, thereby leading to inappropriate estimation of inter-trial variation in signal amplitude 412 
when RMS Error is calculated subsequently. This is not the case for DTW (right).   413 
Figure 3. Use of time-normalization versus non-linear time warping for assessment of upper limb 414 
kinematic variability. Example plots show distal-to-proximal forearm acceleration for an anatomically 415 
intact individual (top), an anatomically intact individual using a prosthesis simulator (middle), and an 416 
amputee (bottom), each pouring juice from a carton into a glass. Shown are original signals of 2 trials 417 
(left), the same signals after time normalization (middle) and after time warping (right). A mismatch of 418 
movement components remains after time normalization, whilst temporal alignment is optimized 419 
through use of DTW for more accurate estimation of amplitude variability. 420 
Figure 4. Known-groups assessment (Study 1). Group means and corresponding standard deviations for 421 
temporal variability (Warp Cost, left) and amplitude variability (RMS Error, right) for all functional tasks. 422 
Figure 5. Responsiveness assessment (Study 2). Group means and corresponding standard deviations 423 
for temporal variability (Warp Cost, left) and amplitude variability (RMS Error, right). Anatomic: baseline 424 
with anatomic hand; Prosthesis 1: first session with a myoelectric prosthesis simulator, Prosthesis Final: 425 
final session with a prosthesis simulator (after four SHAP training sessions). 426 
 427 
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 428 
Figure 1. 429 
  430 
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 431 
Figure 2. 432 
  433 
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 434 
Healthy subject anatomic arm “carton pouring task”: 435 
 436 
Healthy subject prosthesis simulator “carton pouring task”: 437 
 438 
Myoelectric prosthesis user “carton pouring task”: 439 
Figure 3. 440 
  441 
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 443 
Figure 4. 444 
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 447 
Figure 5. 448 
